Literature DB >> 30280322

Interactions of cantharidin-like inhibitors with human protein phosphatase-5 in a Mg2+ system: molecular dynamics and quantum calculations.

Letícia C Assis1, Alexandre A de Castro1, Ingrid G Prandi1, Daiana T Mancini1, Juliana O S de Giacoppo1, Ranylson M L Savedra2, Tamiris M de Assis1, Juliano B Carregal3, Elaine F F da Cunha1, Teodorico Castro Ramalho4,5.   

Abstract

The serine/threonine protein phosphatase type 5 (PP5) is a promising target for designing new antitumor drugs. This enzyme is a member of the PPP phosphatases gene family, which catalyzes a dephosphorylation reaction: a regulatory process in the signal transduction pathway that controls various biological processes. The aim of this work is to study and compare the inhibition of PP5 by ten cantharidin-like inhibitors in order to bring about contributions relevant to the better comprehension of their inhibitory activity. In this theoretical investigation, we used molecular dynamics techniques to understand the role of key interactions that occur in the protein active site; QM calculations were employed to study the interaction mode of these inhibitors in the enzyme. In addition, atoms in molecules (AIM) calculations were carried out to characterize the chemical bonds among the atoms involved and investigate the orbital interactions with their respective energy values. The obtained results suggest that the Arg275, Asn303, His304, His352, Arg400, His427, Glu428, Val429, Tyr451, and Phe446 residues favorably contribute to the interactions between inhibitors and PP5. However, the Asp271 and Asp244 amino acid residues do not favor such interactions for some inhibitors. Through the QM calculations, we can suggest that the reactional energy of the coordination mechanism of these inhibitors in the PP5 active site is quite important and is responsible for the inhibitory activity. The AIM technique employed in this work was essential to get a better comprehension of the transition states acquired from the mechanism simulation. This work offers insights of how cantharidin-like inhibitors interact with human PP5, potentially allowing the design of more specific and even less cytotoxic drugs for cancer treatments. Graphical Abstract Interactions of cantharidin-like inhibitors with human protein phosphatase-5 in a Mg2+ system.

Entities:  

Keywords:  AIM; Cantharidin-like inhibitors; Molecular dynamics; QM/MM; Serine/threonine phosphatase 5

Mesh:

Substances:

Year:  2018        PMID: 30280322     DOI: 10.1007/s00894-018-3837-y

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  23 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  LQTA-QSAR: a new 4D-QSAR methodology.

Authors:  João Paulo A Martins; Euzébio G Barbosa; Kerly F M Pasqualoto; Márcia M C Ferreira
Journal:  J Chem Inf Model       Date:  2009-06       Impact factor: 4.956

3.  QSAR analysis on tacrine-related acetylcholinesterase inhibitors.

Authors:  Kai Y Wong; Andrew G Mercader; Laura M Saavedra; Bahareh Honarparvar; Gustavo P Romanelli; Pablo R Duchowicz
Journal:  J Biomed Sci       Date:  2014-09-20       Impact factor: 8.410

4.  Molecular Docking, Metal Substitution and Hydrolysis Reaction of Chiral Substrates of Phosphotriesterase.

Authors:  Alexandre A de Castro; Melissa S Caetano; Telles C Silva; Daiana T Mancini; Eduardo Pereira Rocha; Elaine F F da Cunha; Teodorico C Ramalho
Journal:  Comb Chem High Throughput Screen       Date:  2016       Impact factor: 1.339

5.  Foundations of biomolecular modeling.

Authors:  William L Jorgensen
Journal:  Cell       Date:  2013-12-05       Impact factor: 41.582

6.  Modeling the antiferromagnetic MnIIMnII system within the protein phosphatase-5 catalytic site.

Authors:  E A Salter; R E Honkanen; A Wierzbicki
Journal:  J Mol Model       Date:  2015-01-24       Impact factor: 1.810

7.  Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin.

Authors:  I Bertini; V Calderone; M Fragai; C Luchinat; E Talluri
Journal:  J Med Chem       Date:  2009-08-13       Impact factor: 7.446

8.  Structural basis for the catalytic activity of human serine/threonine protein phosphatase-5.

Authors:  Mark R Swingle; Richard E Honkanen; Ewa M Ciszak
Journal:  J Biol Chem       Date:  2004-05-23       Impact factor: 5.157

Review 9.  The role of serine/threonine protein phosphatase type 5 (PP5) in the regulation of stress-induced signaling networks and cancer.

Authors:  Teresa Golden; Mark Swingle; Richard E Honkanen
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

10.  Structural and functional basis of protein phosphatase 5 substrate specificity.

Authors:  Jasmeen Oberoi; Diana M Dunn; Mark R Woodford; Laura Mariotti; Jacqualyn Schulman; Dimitra Bourboulia; Mehdi Mollapour; Cara K Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.